Skip to content

Global MDR and XDR TB control needs extra $2.15 billion by end of 2008, says WHO

TB treatment and HBV: risk factors for liver toxicity in South Africans on antiretroviral therapy

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Disregard of no-fly instruction leads to forcible isolation of man with XDR-TB in the US

HIV-positive patients may need longer duration of TB treatment

Gay men who use methamphetamine have greater risk of HIV seroconversion

HIV contributes to lung cancer risk, independent of smoking

Artemether-lumefantrine most effective combination therapy for uncomplicated malaria in Ugandan children